HCA Healthcare Inc (NYSE:HCA) SVP Kathryn A. Torres sold 820 shares of the firm’s stock in a transaction dated Tuesday, November 13th. The shares were sold at an average price of $142.36, for a total value of $116,735.20. Following the sale, the senior vice president now directly owns 4,237 shares in the company, valued at $603,179.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Shares of HCA stock traded down $2.11 during trading hours on Thursday, hitting $137.74. The stock had a trading volume of 2,628,212 shares, compared to its average volume of 1,942,892. HCA Healthcare Inc has a one year low of $74.26 and a one year high of $144.96. The stock has a market capitalization of $48.84 billion, a price-to-earnings ratio of 20.90, a price-to-earnings-growth ratio of 1.24 and a beta of 0.48.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, October 30th. The company reported $2.16 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.93 by $0.23. HCA Healthcare had a negative return on equity of 73.71% and a net margin of 6.82%. The firm had revenue of $11.45 billion for the quarter, compared to analysts’ expectations of $11.29 billion. During the same period in the previous year, the firm posted $1.13 earnings per share. The business’s revenue was up 7.1% compared to the same quarter last year. As a group, research analysts forecast that HCA Healthcare Inc will post 9.35 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 28th. Shareholders of record on Monday, December 3rd will be paid a dividend of $0.35 per share. The ex-dividend date is Friday, November 30th. This represents a $1.40 annualized dividend and a yield of 1.02%. HCA Healthcare’s payout ratio is currently 21.24%.

A number of hedge funds and other institutional investors have recently modified their holdings of HCA. Campbell & CO Investment Adviser LLC bought a new stake in HCA Healthcare during the second quarter worth approximately $259,000. Bank of Montreal Can increased its stake in HCA Healthcare by 49.5% during the second quarter. Bank of Montreal Can now owns 506,077 shares of the company’s stock worth $51,922,000 after acquiring an additional 167,599 shares during the last quarter. Smithfield Trust Co. increased its stake in HCA Healthcare by 541.9% during the second quarter. Smithfield Trust Co. now owns 995 shares of the company’s stock worth $102,000 after acquiring an additional 840 shares during the last quarter. World Asset Management Inc increased its stake in HCA Healthcare by 12.1% during the second quarter. World Asset Management Inc now owns 20,055 shares of the company’s stock worth $2,058,000 after acquiring an additional 2,158 shares during the last quarter. Finally, Amalgamated Bank increased its stake in HCA Healthcare by 15.6% during the second quarter. Amalgamated Bank now owns 41,130 shares of the company’s stock worth $4,220,000 after acquiring an additional 5,562 shares during the last quarter. 70.29% of the stock is currently owned by institutional investors.

A number of equities research analysts have commented on the company. Mizuho reissued a “buy” rating and set a $145.00 price target on shares of HCA Healthcare in a report on Thursday, August 2nd. UBS Group assumed coverage on HCA Healthcare in a report on Thursday. They set a “buy” rating on the stock. Barclays assumed coverage on HCA Healthcare in a report on Tuesday, August 14th. They set an “overweight” rating and a $150.00 price target on the stock. ValuEngine raised HCA Healthcare from a “hold” rating to a “buy” rating in a report on Wednesday, July 18th. Finally, Jefferies Financial Group reissued a “buy” rating and set a $135.00 price target on shares of HCA Healthcare in a report on Thursday, July 26th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company’s stock. HCA Healthcare currently has an average rating of “Buy” and an average price target of $141.53.

WARNING: “HCA Healthcare Inc (HCA) SVP Kathryn A. Torres Sells 820 Shares” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.thecerbatgem.com/2018/11/15/hca-healthcare-inc-hca-svp-kathryn-a-torres-sells-820-shares.html.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: What are the economic characteristics of a bear market?

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.